Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

GFIA: Mid-sized Asian hedge funds outperform both on absolute and risk adjusted basis

Thursday, August 01, 2013

Komfie Manalo, Opalesque Asia:

Mid-size Asian hedge funds, particularly those running assets of between $75m and $150m, outperformed both absolute and risk adjusted basis, said Singapore-based hedge fund data provider GFIA in its July Insights report.

Peter Douglas, GFIA founder, writes, "Mid-sized funds tend to experience lower volatilities than smaller and larger funds in terms of both returns and asset flows. Larger funds, on the other hand, could find it more challenging to maneuver their portfolios in Asia markets and tend to see greater fluctuation of capital flows which probably contributed to the less optimal returns reported. The sweet spot also depends on the strategy and the market that the fund invests in, and although there is no one consistent sweet spot across all strategies, generally running a mid-sized fund seems to be the more viable strategy in Asia."

GFIA studied data from 507 funds from AsiaHedge and Eurekahedge that have track records spanning the period from Jan 2009 to May 2013. Among their findings, they found that smaller funds with less than $50m in assets, outperformed on an absolute return basis across all strategies. While the correlations for very large funds to market indices and hedge fund peers were generally low, the smallest funds tended to have the highest correlations to indices.

The report noted that smaller funds saw a much more volatile cumulative return curve than ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its